LT3546456T - Pirido[3,4-d]pirimidino dariniai arba jo solvato kristalas - Google Patents

Pirido[3,4-d]pirimidino dariniai arba jo solvato kristalas

Info

Publication number
LT3546456T
LT3546456T LTEPPCT/JP2017/042437T LT17873876T LT3546456T LT 3546456 T LT3546456 T LT 3546456T LT 17873876 T LT17873876 T LT 17873876T LT 3546456 T LT3546456 T LT 3546456T
Authority
LT
Lithuania
Prior art keywords
pyridine
pyrimidine derivatives
solvate crystals
solvate
crystals
Prior art date
Application number
LTEPPCT/JP2017/042437T
Other languages
English (en)
Inventor
Hidetoshi Miyamoto
Tsuyoshi Mizuno
Gen Unoki
Yuki Miyazawa
Naoki Yajima
Original Assignee
Teijin Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Limited filed Critical Teijin Pharma Limited
Publication of LT3546456T publication Critical patent/LT3546456T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Walking Sticks, Umbrellas, And Fans (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEPPCT/JP2017/042437T 2016-11-28 2017-11-27 Pirido[3,4-d]pirimidino dariniai arba jo solvato kristalas LT3546456T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016229973 2016-11-28
PCT/JP2017/042437 WO2018097295A1 (ja) 2016-11-28 2017-11-27 ピリド［３，４－ｄ］ピリミジン誘導体又はその溶媒和物の結晶

Publications (1)

Publication Number Publication Date
LT3546456T true LT3546456T (lt) 2022-03-10

Family

ID=62196036

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/JP2017/042437T LT3546456T (lt) 2016-11-28 2017-11-27 Pirido[3,4-d]pirimidino dariniai arba jo solvato kristalas

Country Status (30)

Country Link
US (1) US11261182B2 (lt)
EP (1) EP3546456B1 (lt)
JP (2) JP6745905B2 (lt)
KR (1) KR102352637B1 (lt)
CN (1) CN109996800B (lt)
AU (1) AU2017364805B2 (lt)
CA (1) CA3041854C (lt)
CL (3) CL2019001420A1 (lt)
CO (1) CO2019005513A2 (lt)
CY (1) CY1125045T1 (lt)
DK (1) DK3546456T3 (lt)
EC (1) ECSP19037197A (lt)
ES (1) ES2905437T3 (lt)
HR (1) HRP20220065T1 (lt)
HU (1) HUE057706T2 (lt)
IL (1) IL266313B2 (lt)
LT (1) LT3546456T (lt)
MA (1) MA45887B1 (lt)
MX (1) MX382362B (lt)
MY (1) MY199852A (lt)
PE (2) PE20191133A1 (lt)
PH (1) PH12019500905A1 (lt)
PL (1) PL3546456T3 (lt)
PT (1) PT3546456T (lt)
RS (1) RS63004B1 (lt)
SI (1) SI3546456T1 (lt)
TW (1) TWI755452B (lt)
UA (1) UA124273C2 (lt)
WO (1) WO2018097295A1 (lt)
ZA (1) ZA201902828B (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022412837A1 (en) * 2021-12-16 2024-06-13 Teijin Pharma Limited Cdk9 inhibitor and use thereof
TW202521113A (zh) * 2023-09-27 2025-06-01 日商帝人製藥股份有限公司 類風濕性關節炎治療藥

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005939A (es) 2002-01-22 2005-01-25 Warner Lambert Co 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas.
MXPA05007503A (es) * 2003-01-17 2005-09-21 Warner Lambert Co Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
AU2004255934B2 (en) 2003-07-11 2010-02-25 Warner-Lambert Company Llc Isethionate salt of a selective CDK4 inhibitor
ES2522346T3 (es) 2008-08-22 2014-11-14 Novartis Ag Compuestos de pirrolopirimidina como inhibidores de CDK
GB201216017D0 (en) 2012-09-07 2012-10-24 Cancer Rec Tech Ltd Inhibitor compounds
BR112016005199B1 (pt) * 2013-08-23 2022-02-22 Neupharma, Inc Certos compostos químicos, composições, e métodos
GB201403536D0 (en) * 2014-02-28 2014-04-16 Cancer Rec Tech Ltd Inhibitor compounds
CN106103434B (zh) * 2014-05-29 2019-05-10 大鹏药品工业株式会社 四氢吡啶并嘧啶化合物或其盐
ES2910226T3 (es) 2014-09-17 2022-05-12 Celgene Quanticel Res Inc Inhibidores de desmetilasa de histonas
SG11201709837RA (en) 2015-05-29 2017-12-28 Teijin Pharma Ltd PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

Also Published As

Publication number Publication date
TW201833105A (zh) 2018-09-16
MY199852A (en) 2023-11-25
PL3546456T3 (pl) 2022-05-02
MX382362B (es) 2025-03-13
RU2019116389A3 (lt) 2021-04-16
JP2020121989A (ja) 2020-08-13
RS63004B1 (sr) 2022-03-31
CA3041854A1 (en) 2018-05-31
CL2021001448A1 (es) 2022-01-14
IL266313A (en) 2019-06-30
US11261182B2 (en) 2022-03-01
CL2021001447A1 (es) 2022-01-14
CL2019001420A1 (es) 2019-08-30
UA124273C2 (uk) 2021-08-18
NZ752990A (en) 2025-08-29
DK3546456T3 (da) 2022-03-07
JP7149980B2 (ja) 2022-10-07
PH12019500905A1 (en) 2019-08-19
EP3546456B1 (en) 2022-01-12
RU2019116389A (ru) 2020-11-30
EP3546456A4 (en) 2020-04-29
US20210276997A1 (en) 2021-09-09
PE20191133A1 (es) 2019-09-02
ZA201902828B (en) 2022-05-25
MA45887A1 (fr) 2020-11-30
CO2019005513A2 (es) 2019-07-31
JPWO2018097295A1 (ja) 2019-06-24
EP3546456A1 (en) 2019-10-02
IL266313B2 (en) 2023-12-01
ES2905437T3 (es) 2022-04-08
MA45887B1 (fr) 2021-04-30
MX2019005717A (es) 2019-08-12
HUE057706T2 (hu) 2022-05-28
PE20250397A1 (es) 2025-02-11
WO2018097295A1 (ja) 2018-05-31
CY1125045T1 (el) 2023-03-24
AU2017364805A1 (en) 2019-05-09
ECSP19037197A (es) 2019-06-30
TWI755452B (zh) 2022-02-21
PT3546456T (pt) 2022-02-28
HRP20220065T1 (hr) 2022-04-15
KR20190067247A (ko) 2019-06-14
CN109996800B (zh) 2021-11-19
AU2017364805A2 (en) 2019-10-24
SI3546456T1 (sl) 2022-04-29
CN109996800A (zh) 2019-07-09
KR102352637B1 (ko) 2022-01-17
IL266313B1 (en) 2023-08-01
AU2017364805B2 (en) 2021-12-16
JP6745905B2 (ja) 2020-08-26
BR112019009448A2 (pt) 2019-07-30
CA3041854C (en) 2025-05-13

Similar Documents

Publication Publication Date Title
HUE071131T2 (hu) Helyettesített 1,2-dihidro-3H-pirazolo[3,4-d]pirimidin-3-on-származékok
DK3846904T3 (da) 5-morpholin-4-yl-pyrazolo[4,3-b]pyridinderivater
LT3583105T (lt) Pirolo [1,2-b]piridazino dariniai
DK3305785T3 (da) Pyrido[3,4-d]pyrimidinderivat og farmaceutisk acceptabelt salt deraf
LT3523301T (lt) Pakeistieji pirazolo[1,5-a]piridino junginiai kaip ret kinazės slopikliai
LT3269370T (lt) Naujas kondensuotas pirimidino junginys arba jo druska
DK3345907T3 (da) Pyrazolo[3,4-d]pyrimidinforbindelser eller salte deraf
IL265166B (en) Anti-influenza virus pyrimidine derivatives
PL3359542T3 (pl) Związki i pochodne spiro[3h-indolo-3,2’-pirolidyno]-2(1h)-onowe jako inhibitory mdm2-p53
MA52802A (fr) Dérivé de pyridone polycyclique
IL283990A (en) Modified oxopyridine derivatives
EP3546458A4 (en) PYRIDO [3,4-D] PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL ACCEPTABLE SALT THEREOF
DK3400225T3 (da) Pentansyrederivater substitueret med pyrrolo-[2,3-b]pyrimidinpyridiner til behandling af influenzavirusinfektioner
LT3820872T (lt) Pirolo[1,2-b]piridazino dariniai
DK3372589T3 (da) Pyrimidinderivat
PT4056557T (pt) Derivados de benzazepina
PL3894410T3 (pl) Podstawione pochodne ksantyny
LT3546456T (lt) Pirido[3,4-d]pirimidino dariniai arba jo solvato kristalas
DK3846903T3 (da) Bicykliske heteroarylderivater
MA45685A (fr) Formes cristallines de 4-cyano-n-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide
ES1175584Y (es) Pieza insertable prolongadora de cambrillones para enfranques
HUE050298T2 (hu) Pirazolo[3,4-D]pirimidin vegyületek vagy annak sói
TH1601000114A (th) อนุพันธ์ไทอีโน [3,2-d] ไพริมิดีน สำหรับการบำบัดการติดเชื้อไวรัส
HK1247146A1 (en) Substituted mono- and polyazanaphthalene derivatives and their use